CGD Experts Examine Cancer Treatment Prioritization In LMICs

Center for Global Development: Does Cancer Treatment Warrant Special Consideration from Health Decision-Makers in Low- and Middle-Income Countries?
Adrian Gheorghe, visiting fellow at the Center for Global Development, and colleagues write, “In this blog we consider whether cancer should receive special attention compared to other diseases and public health concerns when allocating scarce public health resources in low- and middle-income countries (LMICs). By ‘special’ we mean: priority in consideration of cancer treatments as part of value assessments; the criteria used to assess whether a treatment represents good value for money; and the reimbursement mechanisms” (3/9).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.